Spruce Stock

www.spruce.coFinTech / InsuranceFounded: 2016Funding to Date: $110.08MM

Spruce provides nationwide title insurance, closing, escrow, and recording services through proprietary technology, machine learning, and centralized teams, adding transparency and speed to the home buying process.

Register To Buy and Sell Shares

For more details on financing and valuation for Spruce, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Spruce’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Spruce.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Spruce’s Stock

Can you buy Spruce’s stock?
Spruce is not publicly traded on NYSE or NASDAQ in the U.S. To buy Spruce’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Spruce’s stock?
Yes, you can sell stock of a private company like Spruce. Forge can help you sell your Spruce stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Spruce’s stock price?
Spruce is a privately held company and therefore does not have a public stock price. However, you may access Spruce’s private market stock price with Forge Data.
What is Spruce’s stock ticker symbol?
Spruce does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Spruce Biosciences to Participate in the Jefferies London Healthcare Conference
Spruce Biosciences, a late-stage biopharmaceutical company, will participate in the Jefferies London Healthcare Conference on November 14-16, 2023. The company is primarily focused on developing therapies for rare endocrine disorders with significant unmet medical need and is currently developing its product candidate, tildacerfont.
Updated on: May 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.